High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV

PURPOSE: Casirivimab/imdevimab (REGN-COV), a cocktail of neutralizing antibodies against the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, was shown to be an effective treatment and post-exposure prophylaxis measure for coronavirus disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Hiroaki, Miyata, Nobuyuki, Yoshimura, Yukihiro, Tachikawa, Natsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856927/
https://www.ncbi.nlm.nih.gov/pubmed/35181864
http://dx.doi.org/10.1007/s15010-022-01779-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856927/
https://www.ncbi.nlm.nih.gov/pubmed/35181864
http://dx.doi.org/10.1007/s15010-022-01779-x

Ejemplares similares